1323359-80-3

ST362 is an anticancer agent. It acts by disrupting DNA repair and halting growth in prostate, colon, lung and breast cancer cells.

ST362 is a anti-cancer agent. ST362 induces cell apoptosis and inhibits cancer cell growth[1].

[1] University Georgetow, et al. Use of strigolactones and strigolactone analogs for treating proliferative conditions. WO2013042124A1. 2013-07-25.